NRC HEALTH (NRC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 60M 120M 180M Q4 '10: 63.4M Q1 '11: 65.8M Q2 '11: 70M Q3 '11: 72.5M Q4 '11: 75.8M Q1 '12: 78.4M Q2 '12: 80.7M Q3 '12: 83.5M Q4 '12: 86.4M Q1 '13: 88.9M Q2 '13: 90.6M Q3 '13: 91.7M Q4 '13: 92.6M Q1 '14: 93.7M Q2 '14: 95.4M Q3 '14: 96.6M Q4 '14: 98.8M Q1 '15: 99.1M Q2 '15: 99.5M Q3 '15: 101.1M Q4 '15: 102.3M Q1 '16: 103.9M Q2 '16: 105.6M Q3 '16: 107.4M Q4 '16: 109.4M Q1 '17: 111.8M Q2 '17: 114.1M Q3 '17: 116M Q4 '17: 117.6M Q1 '18: 118.3M Q2 '18: 117.9M Q3 '18: 118.9M Q4 '18: 119.7M Q1 '19: 120.1M Q2 '19: 123.5M Q3 '19: 126M Q4 '19: 128M Q1 '20: 130.4M Q2 '20: 130.1M Q3 '20: 131.1M Q4 '20: 133.3M Q1 '21: 134.9M Q2 '21: 140.1M Q3 '21: 144.4M Q4 '21: 148M Q1 '22: 150.9M Q2 '22: 151.8M Q3 '22: 151.7M Q4 '22: 151.6M Q1 '23: 149.6M Q2 '23: 148.5M Q3 '23: 148.7M Q4 '23: 148.6M Q1 '24: 147.4M Q2 '24: 146.3M Q3 '24: 144.2M Q4 '24: 143.1M Q1 '25: 141.3M Q2 '25: 140.3M Q3 '25: 139.1M Q4 '25: 137.4M Q1 '26: 138.6M Q2 '26: 140M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 20M 40M 60M Q4 '10: 13.9M Q1 '11: 14.2M Q2 '11: 15.4M Q3 '11: 16.1M Q4 '11: 18.7M Q1 '12: 19.1M Q2 '12: 20.5M Q3 '12: 22M Q4 '12: 22.7M Q1 '13: 23.9M Q2 '13: 24.2M Q3 '13: 24.6M Q4 '13: 24.8M Q1 '14: 26M Q2 '14: 26.8M Q3 '14: 27.9M Q4 '14: 28.3M Q1 '15: 25.7M Q2 '15: 25.8M Q3 '15: 25.2M Q4 '15: 26.4M Q1 '16: 28.6M Q2 '16: 29.3M Q3 '16: 30.1M Q4 '16: 31.2M Q1 '17: 33.2M Q2 '17: 34.6M Q3 '17: 34.4M Q4 '17: 34.2M Q1 '18: 33.2M Q2 '18: 32.5M Q3 '18: 34.5M Q4 '18: 35.3M Q1 '19: 37M Q2 '19: 39.4M Q3 '19: 40.5M Q4 '19: 43M Q1 '20: 43.5M Q2 '20: 42.7M Q3 '20: 44.5M Q4 '20: 42.7M Q1 '21: 43.5M Q2 '21: 46.5M Q3 '21: 47.6M Q4 '21: 50.3M Q1 '22: 49.9M Q2 '22: 49.2M Q3 '22: 47.2M Q4 '22: 46.5M Q1 '23: 43.9M Q2 '23: 41.7M Q3 '23: 40.6M Q4 '23: 40M Q1 '24: 39.8M Q2 '24: 39.3M Q3 '24: 37.3M Q4 '24: 35.2M Q1 '25: 35M Q2 '25: 27.8M Q3 '25: 27.5M Q4 '25: 22.6M Q1 '26: 19.6M Q2 '26: 14.7M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

0 15M 30M 45M Q4 '10: 11.6M Q1 '11: 8.8M Q2 '11: 9.5M Q3 '11: 10M Q4 '11: 11.6M Q1 '12: 12M Q2 '12: 13.6M Q3 '12: 14.5M Q4 '12: 15.1M Q1 '13: 15.7M Q2 '13: 15.2M Q3 '13: 15.4M Q4 '13: 15.5M Q1 '14: 16.5M Q2 '14: 17.1M Q3 '14: 17.8M Q4 '14: 18.2M Q1 '15: 16.2M Q2 '15: 16.2M Q3 '15: 15.8M Q4 '15: 17.6M Q1 '16: 19.6M Q2 '16: 20.1M Q3 '16: 20.7M Q4 '16: 20.5M Q1 '17: 21.5M Q2 '17: 22.7M Q3 '17: 22.2M Q4 '17: 22.9M Q1 '18: 23.7M Q2 '18: 25.9M Q3 '18: 28.8M Q4 '18: 30M Q1 '19: 30.9M Q2 '19: 30.4M Q3 '19: 31.5M Q4 '19: 32.4M Q1 '20: 36M Q2 '20: 36.3M Q3 '20: 37.7M Q4 '20: 37.3M Q1 '21: 34.7M Q2 '21: 36M Q3 '21: 36M Q4 '21: 37.5M Q1 '22: 36.8M Q2 '22: 36.2M Q3 '22: 34.8M Q4 '22: 31.8M Q1 '23: 30.2M Q2 '23: 29.2M Q3 '23: 28.8M Q4 '23: 31M Q1 '24: 30.4M Q2 '24: 29.3M Q3 '24: 27.1M Q4 '24: 24.8M Q1 '25: 24.2M Q2 '25: 17.9M Q3 '25: 16.4M Q4 '25: 11.6M Q1 '26: 9M Q2 '26: 5.9M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 20M 40M 60M Q2 '11: 13.7M Q3 '11: 16.6M Q4 '11: 18.5M Q1 '12: 16.7M Q2 '12: 18M Q3 '12: 17.7M Q4 '12: 19.1M Q1 '13: 20.2M Q2 '13: 17.3M Q3 '13: 20.9M Q4 '13: 19.3M Q1 '14: 21.4M Q2 '14: 24.7M Q3 '14: 24.6M Q4 '14: 26.2M Q1 '15: 22.6M Q2 '15: 24.1M Q3 '15: 20.4M Q4 '15: 21.9M Q1 '16: 24.7M Q2 '16: 23.9M Q3 '16: 25.1M Q4 '16: 26.8M Q1 '17: 30.6M Q2 '17: 26.2M Q3 '17: 30.3M Q4 '17: 28.1M Q1 '18: 28.2M Q2 '18: 35.9M Q3 '18: 32.5M Q4 '18: 39.8M Q1 '19: 38.9M Q2 '19: 37.6M Q3 '19: 42.9M Q4 '19: 40.9M Q1 '20: 39.1M Q2 '20: 38.7M Q3 '20: 36.4M Q4 '20: 40.6M Q1 '21: 49.5M Q2 '21: 52.3M Q3 '21: 50.5M Q4 '21: 46.3M Q1 '22: 40.2M Q2 '22: 38.9M Q3 '22: 40.2M Q4 '22: 36.3M Q1 '23: 35.7M Q2 '23: 34.7M Q3 '23: 34.5M Q4 '23: 38.1M Q1 '24: 42.4M Q2 '24: 40.3M Q3 '24: 40M Q4 '24: 34.6M Q1 '25: 29.2M Q2 '25: 21.3M Q3 '25: 25.6M Q4 '25: 26.4M Q1 '26: 27M Q2 '26: 29.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

0 20M 40M 60M Q2 '11: 11.4M Q3 '11: 13.9M Q4 '11: 15.7M Q1 '12: 14M Q2 '12: 15.2M Q3 '12: 15.3M Q4 '12: 16.8M Q1 '13: 18M Q2 '13: 15.3M Q3 '13: 18.9M Q4 '13: 17.1M Q1 '14: 19M Q2 '14: 22.1M Q3 '14: 21.9M Q4 '14: 23.7M Q1 '15: 20M Q2 '15: 21.4M Q3 '15: 17.8M Q4 '15: 18.9M Q1 '16: 21.4M Q2 '16: 20.4M Q3 '16: 21.3M Q4 '16: 22.9M Q1 '17: 26.3M Q2 '17: 22.1M Q3 '17: 26.1M Q4 '17: 23.5M Q1 '18: 23.7M Q2 '18: 30.9M Q3 '18: 26.5M Q4 '18: 33.9M Q1 '19: 33.1M Q2 '19: 32.1M Q3 '19: 38.3M Q4 '19: 36.3M Q1 '20: 35M Q2 '20: 34.9M Q3 '20: 32.7M Q4 '20: 36.7M Q1 '21: 44.9M Q2 '21: 46.9M Q3 '21: 45.1M Q4 '21: 40.8M Q1 '22: 33.4M Q2 '22: 32.3M Q3 '22: 30.6M Q4 '22: 26.4M Q1 '23: 25.2M Q2 '23: 21.3M Q3 '23: 20.5M Q4 '23: 22.3M Q1 '24: 25.7M Q2 '24: 22.7M Q3 '24: 25.2M Q4 '24: 19.2M Q1 '25: 14.9M Q2 '25: 9.3M Q3 '25: 11.6M Q4 '25: 15.7M Q1 '26: 17.4M Q2 '26: 21.6M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q2 '10: 6.7M Q3 '10: 6.7M Q1 '11: 6.8M Q2 '11: 6.9M Q3 '11: 6.8M Q1 '12: 6.9M Q2 '12: 6.9M Q3 '12: 7M Q1 '13: 7M Q1 '19: 25.5M Q2 '19: 25.6M Q3 '19: 25.7M Q1 '20: 25.7M Q2 '20: 25.7M Q3 '20: 25.7M Q1 '21: 25.7M Q2 '21: 25.6M Q3 '21: 25.6M Q1 '22: 25.4M Q2 '22: 25.2M Q3 '22: 24.8M Q1 '23: 24.7M Q2 '23: 24.7M Q3 '23: 24.7M Q1 '24: 24M Q2 '24: 23.9M Q3 '24: 23.7M Q1 '25: 23M Q2 '25: 22.7M Q3 '25: 22.1M Q1 '26: 21.9M Q2 '26: 22M Q2 '11 Q3 '12 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 20.00 40.00 60.00 Q4 '10: 1.26 Q1 '11: 1.31 Q2 '11: 1.40 Q3 '11: 1.47 Q4 '11: 1.70 Q1 '12: 1.75 Q2 '12: 1.98 Q3 '12: 2.10 Q4 '12: 2.17 Q1 '13: 2.25 Q4 '19: 1.26 Q1 '20: 1.40 Q2 '20: 1.41 Q3 '20: 1.47 Q4 '20: 1.45 Q1 '21: 1.35 Q2 '21: 1.40 Q3 '21: 1.41 Q4 '21: 1.47 Q1 '22: 1.45 Q2 '22: 1.43 Q3 '22: 1.38 Q4 '22: 1.27 Q1 '23: 1.21 Q2 '23: 1.17 Q3 '23: 1.16 Q4 '23: 1.25 Q1 '24: 1.24 Q2 '24: 1.21 Q3 '24: 1.13 Q4 '24: 1.05 Q1 '25: 1.03 Q2 '25: 0.76 Q3 '25: 0.70 Q4 '25: 49.99 Q1 '26: 49.88 Q2 '26: 49.74 Q1 '11 Q2 '12 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.